These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

473 related items for PubMed ID: 16161037

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Sentinel lymph node dissection provides axillary control equal to complete axillary node dissection in breast cancer patients with lobular histology and a negative sentinel node.
    Khakpour N, Hunt KK, Kuerer HM, Yi M, Meric-Bernstam F, Ross MI, Lucci A.
    Am J Surg; 2005 Oct; 190(4):598-601. PubMed ID: 16164930
    [Abstract] [Full Text] [Related]

  • 3. Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011.
    Lucci A, McCall LM, Beitsch PD, Whitworth PW, Reintgen DS, Blumencranz PW, Leitch AM, Saha S, Hunt KK, Giuliano AE, American College of Surgeons Oncology Group.
    J Clin Oncol; 2007 Aug 20; 25(24):3657-63. PubMed ID: 17485711
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Axillary recurrence in women with a negative sentinel lymph node and no axillary dissection in breast cancer.
    Palesty JA, Foster JM, Hurd TC, Watroba N, Rezaishiraz H, Edge SB.
    J Surg Oncol; 2006 Feb 01; 93(2):129-32. PubMed ID: 16425295
    [Abstract] [Full Text] [Related]

  • 6. Patients with breast cancer and negative sentinel lymph node biopsy without additional axillary lymph node dissection: a follow-up study of up to 5 years.
    Domènech A, Benitez A, Bajén MT, Pla MJ, Gil M, Martín-Comín J.
    Oncology; 2007 Feb 01; 72(1-2):27-32. PubMed ID: 17998787
    [Abstract] [Full Text] [Related]

  • 7. Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer.
    Bilimoria KY, Bentrem DJ, Hansen NM, Bethke KP, Rademaker AW, Ko CY, Winchester DP, Winchester DJ.
    J Clin Oncol; 2009 Jun 20; 27(18):2946-53. PubMed ID: 19364968
    [Abstract] [Full Text] [Related]

  • 8. Omitting axillary lymph node dissection in sentinel node negative breast cancer patients is safe: a long term follow-up analysis.
    Torrenga H, Fabry H, van der Sijp JR, van Diest PJ, Pijpers R, Meijer S.
    J Surg Oncol; 2004 Oct 01; 88(1):4-7; discussion 7-8. PubMed ID: 15384064
    [Abstract] [Full Text] [Related]

  • 9. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
    Marrazzo A, Taormina P, Gebbiab V, David M, Riili I, Lo Gerfo D, Casà L, Noto A.
    Chir Ital; 2007 Oct 01; 59(5):693-9. PubMed ID: 18019642
    [Abstract] [Full Text] [Related]

  • 10. Axillary recurrence rate after tumour negative and micrometastatic positive sentinel node procedures in breast cancer patients, a population based multicenter study.
    Bulte CS, van der Heiden-van der Loo M, Hennipman A.
    Eur J Surg Oncol; 2009 Jan 01; 35(1):25-31. PubMed ID: 18640809
    [Abstract] [Full Text] [Related]

  • 11. Survival after negative sentinel lymph node biopsy in breast cancer at least equivalent to after negative extensive axillary dissection.
    Kuijt GP, van de Poll-Franse LV, Voogd AC, Nieuwenhuijzen GA, Roumen RM.
    Eur J Surg Oncol; 2007 Sep 01; 33(7):832-7. PubMed ID: 17197151
    [Abstract] [Full Text] [Related]

  • 12. [Management of the axilla in breast cancer: evidences and unresolved issues].
    Fodor J, Polgár C, Péley G, Németh G.
    Orv Hetil; 2001 Sep 09; 142(36):1941-50. PubMed ID: 11680099
    [Abstract] [Full Text] [Related]

  • 13. Axillary and extra-axillary lymph node recurrences after a tumor-negative sentinel node biopsy for breast cancer using intralesional tracer administration.
    van der Ploeg IM, Kroon BB, Antonini N, Valdés Olmos RA, Rutgers EJ, Nieweg OE.
    Ann Surg Oncol; 2008 Apr 09; 15(4):1025-31. PubMed ID: 18219534
    [Abstract] [Full Text] [Related]

  • 14. Breast sentinel lymph node dissection before preoperative chemotherapy.
    Grube BJ, Christy CJ, Black D, Martel M, Harris L, Weidhaas J, Digiovanna MP, Chung G, Abu-Khalaf MM, Miller KD, Higgins SA, Philpotts L, Tavassoli FA, Lannin DR.
    Arch Surg; 2008 Jul 09; 143(7):692-9; discussion 699-700. PubMed ID: 18645113
    [Abstract] [Full Text] [Related]

  • 15. Staging of women with breast cancer after introduction of sentinel node guided axillary dissection.
    Tvedskov TF.
    Dan Med J; 2012 Jul 09; 59(7):B4475. PubMed ID: 22759850
    [Abstract] [Full Text] [Related]

  • 16. Axillary recurrence rate in breast cancer patients with negative sentinel lymph node.
    Snoj M, Bracko M, Zagar I.
    Croat Med J; 2005 Jun 09; 46(3):377-81. PubMed ID: 15861515
    [Abstract] [Full Text] [Related]

  • 17. Axillary recurrences after negative sentinel lymph node biopsy under local anaesthesia for breast cancer: a follow-up study after 5 years.
    Groetelaers RP, van Berlo CL, Nijhuis PH, Schapers RF, Gerritsen HA.
    Eur J Surg Oncol; 2009 Feb 09; 35(2):159-63. PubMed ID: 18789841
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Critical study of our initial experience of 993 sentinel node biopsies for breast surgery].
    Martel P, Capdet J, Méry E, Zerdoud S, Ferron G, Rafii A, Roché H, Querleu D.
    Bull Cancer; 2008 Feb 09; 95(7):763-72. PubMed ID: 18755653
    [Abstract] [Full Text] [Related]

  • 20. Paget's disease of the breast: the experience of the European Institute of Oncology and review of the literature.
    Caliskan M, Gatti G, Sosnovskikh I, Rotmensz N, Botteri E, Musmeci S, Rosali dos Santos G, Viale G, Luini A.
    Breast Cancer Res Treat; 2008 Dec 09; 112(3):513-21. PubMed ID: 18240020
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.